Coming Soon

A5360: Minimal Versus Standard Monitoring for the Delivery of All Oral Ribavirin-Free Pan Genotypic Directly Acting Antivirals to Chronically Infected Treatment Naïve HCV Populations Globally: MINMON Study

A5345 : Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment VIral Control during an Intensively Monitored Antiretroviral Pause (IMAP)


A5354: Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1 Specific Immune Responses